nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—chronic obstructive pulmonary disease	0.24	0.509	CbGaD
Pentamidine—CYP1A2—chronic obstructive pulmonary disease	0.232	0.491	CbGaD
Pentamidine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.037	0.117	CbGbCtD
Pentamidine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.037	0.117	CbGbCtD
Pentamidine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0334	0.105	CbGbCtD
Pentamidine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.029	0.0915	CbGbCtD
Pentamidine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0281	0.0887	CbGbCtD
Pentamidine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0281	0.0887	CbGbCtD
Pentamidine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0251	0.0791	CbGbCtD
Pentamidine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0236	0.0744	CbGbCtD
Pentamidine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0159	0.0503	CbGbCtD
Pentamidine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0155	0.049	CbGbCtD
Pentamidine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0152	0.048	CbGbCtD
Pentamidine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0136	0.0427	CbGbCtD
Pentamidine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00796	0.0251	CbGbCtD
Pentamidine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00751	0.0237	CbGbCtD
Pentamidine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00138	CcSEcCtD
Pentamidine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00138	CcSEcCtD
Pentamidine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00137	CcSEcCtD
Pentamidine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Pentamidine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Pentamidine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Pentamidine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Pentamidine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Pentamidine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.00137	CcSEcCtD
Pentamidine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00136	CcSEcCtD
Pentamidine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00136	CcSEcCtD
Pentamidine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00136	CcSEcCtD
Pentamidine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00136	CcSEcCtD
Pentamidine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00134	CcSEcCtD
Pentamidine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00134	CcSEcCtD
Pentamidine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00134	CcSEcCtD
Pentamidine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00134	CcSEcCtD
Pentamidine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00134	CcSEcCtD
Pentamidine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00134	CcSEcCtD
Pentamidine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00134	CcSEcCtD
Pentamidine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00133	CcSEcCtD
Pentamidine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00133	CcSEcCtD
Pentamidine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00133	CcSEcCtD
Pentamidine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00131	CcSEcCtD
Pentamidine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00131	CcSEcCtD
Pentamidine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00131	CcSEcCtD
Pentamidine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00131	CcSEcCtD
Pentamidine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00131	CcSEcCtD
Pentamidine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.0013	CcSEcCtD
Pentamidine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.0013	CcSEcCtD
Pentamidine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.0013	CcSEcCtD
Pentamidine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00129	CcSEcCtD
Pentamidine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00129	CcSEcCtD
Pentamidine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.00129	CcSEcCtD
Pentamidine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00129	CcSEcCtD
Pentamidine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00128	CcSEcCtD
Pentamidine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00128	CcSEcCtD
Pentamidine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00128	CcSEcCtD
Pentamidine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00128	CcSEcCtD
Pentamidine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00127	CcSEcCtD
Pentamidine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00127	CcSEcCtD
Pentamidine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00126	CcSEcCtD
Pentamidine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00126	CcSEcCtD
Pentamidine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00124	CcSEcCtD
Pentamidine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00123	CcSEcCtD
Pentamidine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00123	CcSEcCtD
Pentamidine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00123	CcSEcCtD
Pentamidine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00123	CcSEcCtD
Pentamidine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000172	0.00122	CcSEcCtD
Pentamidine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00122	CcSEcCtD
Pentamidine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00121	CcSEcCtD
Pentamidine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00121	CcSEcCtD
Pentamidine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.0012	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000169	0.0012	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.0012	CcSEcCtD
Pentamidine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00119	CcSEcCtD
Pentamidine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00119	CcSEcCtD
Pentamidine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00118	CcSEcCtD
Pentamidine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.00118	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Pentamidine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Pentamidine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Pentamidine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00117	CcSEcCtD
Pentamidine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00117	CcSEcCtD
Pentamidine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00116	CcSEcCtD
Pentamidine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00116	CcSEcCtD
Pentamidine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00116	CcSEcCtD
Pentamidine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00116	CcSEcCtD
Pentamidine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00116	CcSEcCtD
Pentamidine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.00115	CcSEcCtD
Pentamidine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00114	CcSEcCtD
Pentamidine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00114	CcSEcCtD
Pentamidine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00113	CcSEcCtD
Pentamidine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Pentamidine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Pentamidine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Pentamidine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Pentamidine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Pentamidine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Pentamidine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Pentamidine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Pentamidine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00111	CcSEcCtD
Pentamidine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00111	CcSEcCtD
Pentamidine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00111	CcSEcCtD
Pentamidine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.0011	CcSEcCtD
Pentamidine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000155	0.0011	CcSEcCtD
Pentamidine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.0011	CcSEcCtD
Pentamidine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00109	CcSEcCtD
Pentamidine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00109	CcSEcCtD
Pentamidine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00109	CcSEcCtD
Pentamidine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00109	CcSEcCtD
Pentamidine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00109	CcSEcCtD
Pentamidine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Pentamidine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Pentamidine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Pentamidine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Pentamidine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Pentamidine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00108	CcSEcCtD
Pentamidine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00108	CcSEcCtD
Pentamidine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00107	CcSEcCtD
Pentamidine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00107	CcSEcCtD
Pentamidine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00106	CcSEcCtD
Pentamidine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00106	CcSEcCtD
Pentamidine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Pentamidine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00104	CcSEcCtD
Pentamidine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00104	CcSEcCtD
Pentamidine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Pentamidine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Pentamidine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Pentamidine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Pentamidine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Pentamidine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00104	CcSEcCtD
Pentamidine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00103	CcSEcCtD
Pentamidine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.00103	CcSEcCtD
Pentamidine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00103	CcSEcCtD
Pentamidine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.00103	CcSEcCtD
Pentamidine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Pentamidine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Pentamidine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Pentamidine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Pentamidine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Pentamidine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Pentamidine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Pentamidine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00102	CcSEcCtD
Pentamidine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000997	CcSEcCtD
Pentamidine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000986	CcSEcCtD
Pentamidine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000981	CcSEcCtD
Pentamidine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000981	CcSEcCtD
Pentamidine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000969	CcSEcCtD
Pentamidine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000969	CcSEcCtD
Pentamidine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.000968	CcSEcCtD
Pentamidine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000965	CcSEcCtD
Pentamidine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000949	CcSEcCtD
Pentamidine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000943	CcSEcCtD
Pentamidine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000943	CcSEcCtD
Pentamidine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00093	CcSEcCtD
Pentamidine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00093	CcSEcCtD
Pentamidine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000924	CcSEcCtD
Pentamidine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000915	CcSEcCtD
Pentamidine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000911	CcSEcCtD
Pentamidine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.0009	CcSEcCtD
Pentamidine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000127	0.0009	CcSEcCtD
Pentamidine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000895	CcSEcCtD
Pentamidine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000892	CcSEcCtD
Pentamidine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000891	CcSEcCtD
Pentamidine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000881	CcSEcCtD
Pentamidine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000878	CcSEcCtD
Pentamidine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000872	CcSEcCtD
Pentamidine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000869	CcSEcCtD
Pentamidine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000869	CcSEcCtD
Pentamidine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000852	CcSEcCtD
Pentamidine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000851	CcSEcCtD
Pentamidine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000849	CcSEcCtD
Pentamidine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000836	CcSEcCtD
Pentamidine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000836	CcSEcCtD
Pentamidine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000829	CcSEcCtD
Pentamidine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000829	CcSEcCtD
Pentamidine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000828	CcSEcCtD
Pentamidine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000828	CcSEcCtD
Pentamidine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000824	CcSEcCtD
Pentamidine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000824	CcSEcCtD
Pentamidine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000822	CcSEcCtD
Pentamidine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000821	CcSEcCtD
Pentamidine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000821	CcSEcCtD
Pentamidine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000819	CcSEcCtD
Pentamidine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000812	CcSEcCtD
Pentamidine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000811	CcSEcCtD
Pentamidine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000807	CcSEcCtD
Pentamidine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000797	CcSEcCtD
Pentamidine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000795	CcSEcCtD
Pentamidine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000789	CcSEcCtD
Pentamidine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000784	CcSEcCtD
Pentamidine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000783	CcSEcCtD
Pentamidine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000782	CcSEcCtD
Pentamidine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000782	CcSEcCtD
Pentamidine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000781	CcSEcCtD
Pentamidine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000781	CcSEcCtD
Pentamidine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000778	CcSEcCtD
Pentamidine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000767	CcSEcCtD
Pentamidine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000765	CcSEcCtD
Pentamidine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000756	CcSEcCtD
Pentamidine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000753	CcSEcCtD
Pentamidine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000741	CcSEcCtD
Pentamidine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000737	CcSEcCtD
Pentamidine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000734	CcSEcCtD
Pentamidine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000725	CcSEcCtD
Pentamidine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000712	CcSEcCtD
Pentamidine—Shock—Prednisolone—chronic obstructive pulmonary disease	9.86e-05	0.000701	CcSEcCtD
Pentamidine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.78e-05	0.000695	CcSEcCtD
Pentamidine—Flushing—Prednisone—chronic obstructive pulmonary disease	9.51e-05	0.000676	CcSEcCtD
Pentamidine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000651	CcSEcCtD
Pentamidine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.06e-05	0.000644	CcSEcCtD
Pentamidine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9e-05	0.000639	CcSEcCtD
Pentamidine—Erythema—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000634	CcSEcCtD
Pentamidine—Pain—Prednisolone—chronic obstructive pulmonary disease	8.57e-05	0.000609	CcSEcCtD
Pentamidine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000598	CcSEcCtD
Pentamidine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.26e-05	0.000587	CcSEcCtD
Pentamidine—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000586	CcSEcCtD
Pentamidine—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000579	CcSEcCtD
Pentamidine—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.00057	CcSEcCtD
Pentamidine—Syncope—Prednisone—chronic obstructive pulmonary disease	8e-05	0.000569	CcSEcCtD
Pentamidine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.96e-05	0.000566	CcSEcCtD
Pentamidine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.000557	CcSEcCtD
Pentamidine—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000549	CcSEcCtD
Pentamidine—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000547	CcSEcCtD
Pentamidine—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.00054	CcSEcCtD
Pentamidine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.00054	CcSEcCtD
Pentamidine—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000538	CcSEcCtD
Pentamidine—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000533	CcSEcCtD
Pentamidine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.38e-05	0.000525	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.3e-05	0.00104	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CRP—chronic obstructive pulmonary disease	7.28e-05	0.00104	CbGpPWpGaD
Pentamidine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000517	CcSEcCtD
Pentamidine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.24e-05	0.00103	CbGpPWpGaD
Pentamidine—Infection—Prednisone—chronic obstructive pulmonary disease	7.23e-05	0.000514	CcSEcCtD
Pentamidine—Shock—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000509	CcSEcCtD
Pentamidine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.15e-05	0.00102	CbGpPWpGaD
Pentamidine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.000505	CcSEcCtD
Pentamidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.06e-05	0.001	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—TLR4—chronic obstructive pulmonary disease	6.98e-05	0.000993	CbGpPWpGaD
Pentamidine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.97e-05	0.000991	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.94e-05	0.000988	CbGpPWpGaD
Pentamidine—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000493	CcSEcCtD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.89e-05	0.00098	CbGpPWpGaD
Pentamidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	6.87e-05	0.000977	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.85e-05	0.000974	CbGpPWpGaD
Pentamidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.75e-05	0.000961	CbGpPWpGaD
Pentamidine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.74e-05	0.000958	CbGpPWpGaD
Pentamidine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000471	CcSEcCtD
Pentamidine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.63e-05	0.000471	CcSEcCtD
Pentamidine—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000468	CcSEcCtD
Pentamidine—S100B—Immune System—TLR2—chronic obstructive pulmonary disease	6.58e-05	0.000936	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.56e-05	0.000933	CbGpPWpGaD
Pentamidine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.54e-05	0.000465	CcSEcCtD
Pentamidine—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.47e-05	0.00092	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.46e-05	0.000919	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.41e-05	0.000912	CbGpPWpGaD
Pentamidine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.41e-05	0.000455	CcSEcCtD
Pentamidine—CYP4A11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.4e-05	0.000911	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.39e-05	0.000908	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.35e-05	0.000903	CbGpPWpGaD
Pentamidine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.00045	CcSEcCtD
Pentamidine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.32e-05	0.000449	CcSEcCtD
Pentamidine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.31e-05	0.000449	CcSEcCtD
Pentamidine—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.000446	CcSEcCtD
Pentamidine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.000446	CcSEcCtD
Pentamidine—CYP4A11—Metabolism—GC—chronic obstructive pulmonary disease	6.23e-05	0.000886	CbGpPWpGaD
Pentamidine—Constipation—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000442	CcSEcCtD
Pentamidine—S100B—Immune System—KL—chronic obstructive pulmonary disease	6.19e-05	0.00088	CbGpPWpGaD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.08e-05	0.000865	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.02e-05	0.000856	CbGpPWpGaD
Pentamidine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6e-05	0.000426	CcSEcCtD
Pentamidine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.96e-05	0.000848	CbGpPWpGaD
Pentamidine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000423	CcSEcCtD
Pentamidine—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.95e-05	0.000423	CcSEcCtD
Pentamidine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.94e-05	0.000845	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.93e-05	0.000844	CbGpPWpGaD
Pentamidine—CYP4A11—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.89e-05	0.000838	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.89e-05	0.000837	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.89e-05	0.000837	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.87e-05	0.000835	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.79e-05	0.000824	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.79e-05	0.000824	CbGpPWpGaD
Pentamidine—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.78e-05	0.000411	CcSEcCtD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.77e-05	0.000821	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.77e-05	0.000821	CbGpPWpGaD
Pentamidine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000409	CcSEcCtD
Pentamidine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000409	CcSEcCtD
Pentamidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.72e-05	0.000814	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.71e-05	0.000813	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.55e-05	0.000789	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.5e-05	0.000782	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.5e-05	0.000782	CbGpPWpGaD
Pentamidine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.48e-05	0.00078	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.47e-05	0.000778	CbGpPWpGaD
Pentamidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.45e-05	0.000775	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.4e-05	0.000768	CbGpPWpGaD
Pentamidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.38e-05	0.000765	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.37e-05	0.000764	CbGpPWpGaD
Pentamidine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000381	CcSEcCtD
Pentamidine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.32e-05	0.000757	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.3e-05	0.000753	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.25e-05	0.000747	CbGpPWpGaD
Pentamidine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000371	CcSEcCtD
Pentamidine—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.000366	CcSEcCtD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.09e-05	0.000724	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.05e-05	0.000718	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.03e-05	0.000716	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.03e-05	0.000715	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.02e-05	0.000714	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD8A—chronic obstructive pulmonary disease	4.99e-05	0.00071	CbGpPWpGaD
Pentamidine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.000354	CcSEcCtD
Pentamidine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.98e-05	0.000708	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.98e-05	0.000708	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.96e-05	0.000705	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.95e-05	0.000704	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.94e-05	0.000702	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.87e-05	0.000693	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.83e-05	0.000687	CbGpPWpGaD
Pentamidine—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000342	CcSEcCtD
Pentamidine—S100B—Immune System—ERBB3—chronic obstructive pulmonary disease	4.64e-05	0.00066	CbGpPWpGaD
Pentamidine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000329	CcSEcCtD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.61e-05	0.000656	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.61e-05	0.000656	CbGpPWpGaD
Pentamidine—Rash—Prednisone—chronic obstructive pulmonary disease	4.59e-05	0.000326	CcSEcCtD
Pentamidine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.59e-05	0.000326	CcSEcCtD
Pentamidine—Headache—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000324	CcSEcCtD
Pentamidine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.55e-05	0.000647	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.54e-05	0.000646	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.48e-05	0.000637	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.42e-05	0.000628	CbGpPWpGaD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.42e-05	0.000628	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.37e-05	0.000622	CbGpPWpGaD
Pentamidine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.32e-05	0.000307	CcSEcCtD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.000613	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.3e-05	0.000612	CbGpPWpGaD
Pentamidine—S100B—Immune System—CRP—chronic obstructive pulmonary disease	4.24e-05	0.000603	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.12e-05	0.000586	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.12e-05	0.000585	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.09e-05	0.000582	CbGpPWpGaD
Pentamidine—S100B—Immune System—TLR4—chronic obstructive pulmonary disease	4.07e-05	0.000578	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.06e-05	0.000578	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.06e-05	0.000577	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.06e-05	0.000577	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KL—chronic obstructive pulmonary disease	4e-05	0.000569	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.9e-05	0.000555	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.89e-05	0.000553	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.85e-05	0.000547	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.84e-05	0.000546	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	3.84e-05	0.000546	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.78e-05	0.000538	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.75e-05	0.000534	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.73e-05	0.000531	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.69e-05	0.000525	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.68e-05	0.000524	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.68e-05	0.000524	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.59e-05	0.00051	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.54e-05	0.000503	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.54e-05	0.000503	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.52e-05	0.0005	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.51e-05	0.000499	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.51e-05	0.000499	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.000496	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EGFR—chronic obstructive pulmonary disease	3.46e-05	0.000492	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.44e-05	0.000489	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.4e-05	0.000484	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GCLC—chronic obstructive pulmonary disease	3.36e-05	0.000478	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.3e-05	0.000469	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.000459	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.000456	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000453	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.16e-05	0.00045	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.14e-05	0.000446	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.14e-05	0.000446	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CTGF—chronic obstructive pulmonary disease	3.07e-05	0.000437	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.000432	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3e-05	0.000427	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.000426	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.89e-05	0.000411	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.89e-05	0.000411	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.83e-05	0.000402	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.73e-05	0.000389	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.69e-05	0.000383	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.69e-05	0.000383	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.68e-05	0.000382	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—IL6—chronic obstructive pulmonary disease	2.66e-05	0.000378	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.66e-05	0.000378	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL1B—chronic obstructive pulmonary disease	2.65e-05	0.000376	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.62e-05	0.000372	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.54e-05	0.000361	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.000358	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.51e-05	0.000357	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000352	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.47e-05	0.000352	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.45e-05	0.000348	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.44e-05	0.000347	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.43e-05	0.000346	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.36e-05	0.000335	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.000334	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.33e-05	0.000331	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.33e-05	0.000331	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000329	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.000329	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.3e-05	0.000327	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.27e-05	0.000322	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.24e-05	0.000318	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.17e-05	0.000308	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.11e-05	0.0003	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.11e-05	0.0003	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.08e-05	0.000296	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000293	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000292	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-05	0.000288	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.000287	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.01e-05	0.000286	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.91e-05	0.000272	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.89e-05	0.000268	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.88e-05	0.000267	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.86e-05	0.000265	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.78e-05	0.000254	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.74e-05	0.000248	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.73e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.000239	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.62e-05	0.00023	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.61e-05	0.000229	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.000224	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL6—chronic obstructive pulmonary disease	1.55e-05	0.00022	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.000213	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-05	0.000208	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.45e-05	0.000206	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.43e-05	0.000203	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.000201	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ALB—chronic obstructive pulmonary disease	1.4e-05	0.000199	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.000192	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.34e-05	0.00019	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.33e-05	0.00019	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.33e-05	0.000189	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.000185	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.000183	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.25e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000177	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000176	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.22e-05	0.000174	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000173	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.22e-05	0.000173	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.000169	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000166	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000162	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.13e-05	0.000161	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.00016	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000159	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000157	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.09e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.000155	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000146	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000145	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.02e-05	0.000145	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1e-05	0.000143	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1e-05	0.000143	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.97e-06	0.000142	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.91e-06	0.000141	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.77e-06	0.000139	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.36e-06	0.000133	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.23e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.18e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.17e-06	0.00013	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.1e-06	0.000129	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.63e-06	0.000123	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.61e-06	0.000122	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.6e-06	0.000122	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.58e-06	0.000122	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.51e-06	0.000121	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.46e-06	0.00012	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.45e-06	0.00012	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.93e-06	0.000113	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.88e-06	0.000112	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.77e-06	0.00011	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.66e-06	0.000109	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.55e-06	0.000107	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.47e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.04e-06	0.0001	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.04e-06	0.0001	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.95e-06	9.88e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.67e-06	9.49e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.64e-06	9.45e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.57e-06	9.34e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.47e-06	9.21e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.14e-06	8.73e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.99e-06	8.52e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.97e-06	8.49e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.88e-06	8.37e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.87e-06	8.34e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.61e-06	7.98e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.54e-06	7.88e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.52e-06	7.85e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.48e-06	7.8e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.3e-06	7.54e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.2e-06	7.39e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	5.08e-06	7.23e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.86e-06	6.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.61e-06	6.55e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.54e-06	6.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.53e-06	6.45e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.34e-06	6.17e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.23e-06	6.02e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.17e-06	5.93e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.01e-06	5.71e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.99e-06	5.68e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.53e-06	5.03e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.38e-06	4.81e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.73e-06	3.88e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.61e-06	3.71e-05	CbGpPWpGaD
